Safety Alert for PATCH ORGANIC BIOMEND, models BIOMEND and BIOMEND EXTEND (Anvisa Registry: 10355870093. Affected lots: 1105175, 1111859 and 1104847 (Biomend Extend); 1111358 and 1111865 (Biomend). ) Affected lots: 1110239 (Colla Plug), 1111644 (Colla Cote) and 1112262 (Colla Tape, see details in the attachment http://portal.anvisa.gov.br/wps/wcm/connect/e73bf38040357a1cb017f0dc5a12ff52/Alerta_Biomend.pdf? MOD = AJPERES

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Biomédica Equipamentos e Suprimentos Hospitalares Ltda..

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1271
  • Date
    2013-07-02
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    During the internal quality assurance review of the company's processes, the manufacturer of the product found that there may have been a deviation of a production process during the manufacture of specific batches of the product. All batches in question have been subjected to final final product release tests, are sterile and have been tested and accepted for endotoxin level. However, due to a deviation in the process, they may have been released with higher levels of endotoxin than allowed by the product specifications. High levels of endotoxin may result in fever in the immediate postoperative period. However, neither the manufacturer nor Biomédica (who owns the product registration in Brazil) received reports or complaints regarding patient injuries or other adverse events related to these batches of products possibly affected. According to Biomedica, communication to affected customers will be made via e-mail or letter to buyers of the product.
  • Reason
    Lots were released with higher levels of endotoxin than allowed by product specifications.
  • Action
    Biomedica Equipamentos e Suprimentos Hospitalares Ltda has already started collecting the target products of this alert. To the users of the products it is recommended: 1) Immediate segregation of the affected products; and 2) The monitoring of patients regarding the occurrence of fever in the immediate postoperative period, according to the protocol of the health establishment.